Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 316 results found. Search for [ DCGI ]

Results 1 to 21 of 316
BusinessToday.In
October 23, 2020
Dr Reddy's Laboratories has been given permission to conduct the trails of Russian COVID-19 vaccine Sputnik V, though, the date and time of the test will be determined by the company


BusinessToday.In
October 23, 2020
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is expected to be at least 60 per cent effective


BusinessToday.In
October 22, 2020
Covaxin, the COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has received the approval of Drugs Controller General of India (DCGI's) Expert Committee to start the final phase of trials


Manoj Sharma
October 22, 2020
Dr Reddy's has partnered with Russian Direct Investment Fund to conduct trials of Sputnik V and distribute vaccine in India; after the cyber attack, its stock is 2.96% or Rs 149.20 down at Rs 4,897.55 compared to previous session's close of Rs 5,046.75


BusinessToday.In
October 19, 2020
Stocks to watch today on October 19: HDFC Bank, Tata Communications, Avenue Supermarts, Bajaj Consumer, RIL among others are the top stocks to watch out for in Monday's trading session


BusinessToday.In
October 18, 2020
Coronavirus vaccine: Meanwhile, the Drug Control General of India (DCGI) on Saturday approved Dr Reddy's proposal to conduct clinical trials for Sputnik V in India


Reuters
October 16, 2020
The company said last month a late-stage study of Avigan had shown reduced recovery times for COVID-19 patients with non-severe symptoms and it would seek to file for approval as early as this month


BusinessToday.In
October 15, 2020
Russian COVID-19 vaccine: Putin said on state TV that they have to increase production of first and second vaccines. \"We are continuing to cooperate with our foreign partners and will promote our vaccine abroad,\" he added


BusinessToday.In
October 14, 2020
Coronavirus vaccine update: Bharat Biotech is ready to start Covaxin's Phase 3 trail to test the vaccine on about 28,500 volunteers


PB Jayakumar
October 14, 2020
The indicated price is for treatment using the drug for about a month, or a treatment cycle depending on the disease progression and patient condition


BusinessToday.In
October 14, 2020
Dr Reddy's has teamed up with Russian Development Investment Fund (RDIF) to conduct trials and distribute 100 million doses of Sputnik V in India


BusinessToday.In
October 11, 2020
The minister also said that based on tests of over 2,000 patients during the trials at the Institute of Genomics and Integrative Biology (IGIB) and on testing in private labs, the test showed 96 per cent sensitivity and 98 per cent specificity


PTI
October 10, 2020
According to sources, the phase-2 trial of the Covaxin is going on and the second dose is yet to be given to volunteers at some sites


Reuters
October 7, 2020
China has at least four experimental vaccines in the final stage of clinical trials


PTI
October 7, 2020
Antisera are blood serum high in antibodies against specific antigens and are injected in humans to help kickstart the immune system to fight specific infections


Reuters
October 6, 2020
The Hyderabad-based pharmaceutical company had applied to the Drugs Controller General of India (DCGI) late last week, seeking permission to conduct phase-3 human clinical trials of the Russian vaccine


BusinessToday.In
October 3, 2020
COVID-19 vaccine: A principal investigator from a trial site in Maharashtra said that they are expecting to finish enrolling the participants within the next two months after which they will be monitored for the vaccine's efficacy


BusinessToday.In
September 29, 2020
Named after Satyajit Ray's popular private detective, FELUDA can differentiate between the COVID-19 virus and other coronavirus even though the genetic variations between them are minute


BusinessToday.In
September 26, 2020
Adar Poonawalla, CEO of the Serum Institute of India (SII), on Saturday expressed his concerns around production and distribution of coronavirus vaccine in the country


BusinessToday.In
September 22, 2020
With the 800 mg of Favipiravir tablet, COVID-19 patients could undergo a more relaxed dosage, which will increase their compliance and experience


PAGES 1 OF 16  12345